Soraya Azzawi

Soraya Azzawi practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Soraya Azzawi's NPI, 1255892063, was assigned on March 26, 2019. Soraya Azzawi graduated from Harvard Medical School in 2019. Soraya Azzawi's California license number on file is A189920.

Soraya Azzawi's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Soraya Azzawi's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Soraya Azzawi is also affiliated with UCLA Santa Monica Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Soraya Azzawi to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Soraya Azzawi practices, 3 sites in all. Vendor and product names are available with a free account.

Rheumatology is Soraya Azzawi's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Soraya Azzawi is board certified in dermatology by the American Board of Dermatology. Soraya Azzawi has a license on file in California.

Dmand AI lists benign or precancerous skin growths and psoriasis among the conditions Soraya Azzawi treats.

CMS data shows 973 Medicare services from Soraya Azzawi across 11 procedure codes in 2024, for 305 Medicare patients. Medicare paid $75,632 for them. Every service was in an office.

CMS counts 305 Medicare patients who saw Soraya Azzawi in 2024. The largest group is 65 to 74, with 165 patients. 75% of them have high cholesterol, and 62% have high blood pressure. 20% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Soraya Azzawi's median patient age at 50, with 60% women.

In 2024, Soraya Azzawi wrote 852 Medicare Part D claims for 274 patients. 93% of them were for generic drugs. CMS names the drug for 686 of them, across 14 drugs with 11 or more claims each, at $21,914 in total drug cost. In 2023, CMS named 74 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Soraya Azzawi for performance year 2024, reported as part of a group. Soraya Azzawi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Soraya Azzawi as offering telehealth. CMS counts 131 procedures of skin biopsy by Soraya Azzawi, more than 79% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 23 general payments to Soraya Azzawi from 8 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $305.

Soraya Azzawi graduated from Harvard Medical School in 2019.

Soraya Azzawi is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.